Publication: To B-(RAF) or not to be
To B-(RAF) or not to be
Date
Date
Date
2014
Journal Article
Published version
| cris.lastimport.scopus | 2025-08-05T03:38:27Z | |
| cris.lastimport.wos | 2025-07-12T01:35:15Z | |
| dc.contributor.institution | University of Zurich | |
| dc.date.accessioned | 2015-02-26T11:43:13Z | |
| dc.date.available | 2015-02-26T11:43:13Z | |
| dc.date.issued | 2014-05 | |
| dc.description.abstract | The identification of targetable mutations has revolutionized the therapy of metastatic melanoma. In particular, BRAF and MEK inhibitors have a well-documented impact on overall survival in metastatic disease. However, therapeutic success is highly dependent on the correct identification of these mutations. We discuss the impact of molecular heterogeneity in this context. | |
| dc.identifier.doi | 10.1038/jid.2014.62 | |
| dc.identifier.issn | 0022-202X | |
| dc.identifier.scopus | 2-s2.0-84900794454 | |
| dc.identifier.uri | https://www.zora.uzh.ch/handle/20.500.14742/86347 | |
| dc.identifier.wos | 000334570300009 | |
| dc.language.iso | eng | |
| dc.subject.ddc | 610 Medicine & health | |
| dc.title | To B-(RAF) or not to be | |
| dc.type | article | |
| dcterms.accessRights | info:eu-repo/semantics/closedAccess | |
| dcterms.bibliographicCitation.journaltitle | Journal of Investigative Dermatology | |
| dcterms.bibliographicCitation.number | 5 | |
| dcterms.bibliographicCitation.originalpublishername | Elsevier | |
| dcterms.bibliographicCitation.pageend | 1201 | |
| dcterms.bibliographicCitation.pagestart | 1200 | |
| dcterms.bibliographicCitation.pmid | 24732335 | |
| dcterms.bibliographicCitation.volume | 134 | |
| dspace.entity.type | Publication | en |
| uzh.contributor.affiliation | University Hospital Zurich, Dermatologische Klinik | |
| uzh.contributor.affiliation | University Hospital Zurich, Dermatologische Klinik | |
| uzh.contributor.affiliation | University Hospital Zurich, Dermatologische Klinik | |
| uzh.contributor.affiliation | University Hospital Zurich, Dermatologische Klinik | |
| uzh.contributor.affiliation | University Hospital Zurich, Dermatologische Klinik | |
| uzh.contributor.author | Dummer, Reinhard | |
| uzh.contributor.author | Goldinger, Simone M | |
| uzh.contributor.author | Widmer, Daniel | |
| uzh.contributor.author | Dreier, Jil | |
| uzh.contributor.author | Levesque, Mitchell P | |
| uzh.contributor.correspondence | Yes | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.contributor.correspondence | No | |
| uzh.document.availability | no_document | |
| uzh.eprint.datestamp | 2015-02-26 11:43:13 | |
| uzh.eprint.lastmod | 2025-08-05 03:38:28 | |
| uzh.eprint.statusChange | 2015-02-26 11:43:13 | |
| uzh.harvester.eth | No | |
| uzh.harvester.nb | No | |
| uzh.jdb.eprintsId | 21300 | |
| uzh.oastatus.unpaywall | bronze | |
| uzh.oastatus.zora | Closed | |
| uzh.publication.citation | Dummer, Reinhard; Goldinger, Simone M; Widmer, Daniel; Dreier, Jil; Levesque, Mitchell P (2014). To B-(RAF) or not to be. Journal of Investigative Dermatology, 134(5):1200-1201. | |
| uzh.publication.freeAccessAt | doi | |
| uzh.publication.originalwork | original | |
| uzh.publication.publishedStatus | final | |
| uzh.scopus.impact | 0 | |
| uzh.scopus.subjects | Biochemistry | |
| uzh.scopus.subjects | Molecular Biology | |
| uzh.scopus.subjects | Dermatology | |
| uzh.scopus.subjects | Cell Biology | |
| uzh.workflow.doaj | uzh.workflow.doaj.false | |
| uzh.workflow.eprintid | 108627 | |
| uzh.workflow.fulltextStatus | none | |
| uzh.workflow.revisions | 50 | |
| uzh.workflow.rightsCheck | keininfo | |
| uzh.workflow.status | archive | |
| uzh.wos.impact | 0 | |
| Publication available in collections: |